Zhitong Finance App News, Cansino (688185.SH) issued an announcement. The adsorbed acell-free 100 (five-component) white burst combination vaccine (for people aged 6 and above) (“Td5cP for young people and adults”) domestically produced drug registration and marketing license application (“Drug Registration Application”) developed by the company recently obtained a “Notice of Acceptance” issued by the China Drug Administration. Td5cp for adolescents and adults is suitable for people aged 6 and above. It is a booster vaccine for adolescents and adults. Major developed countries have included this vaccine in routine vaccination plans, but there is no approved DPT booster vaccine for adolescents and adults in China. If successfully marketed, this product will fill the gap in the domestic market.

Zhitong Finance App News, Cansino (688185.SH) issued an announcement. The adsorbed acell-free 100 (five-component) white burst combination vaccine (for people aged 6 and above) (“Td5cP for young people and adults”) domestically produced drug registration and marketing license application (“Drug Registration Application”) developed by the company recently obtained a “Notice of Acceptance” issued by the China Drug Administration. Td5cp for adolescents and adults is suitable for people aged 6 and above. It is a booster vaccine for adolescents and adults. Major developed countries have included this vaccine in routine vaccination plans, but there is no approved DPT booster vaccine for adolescents and adults in China. If successfully marketed, this product will fill the gap in the domestic market.